Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.12 USD | +0.95% | -7.75% | -12.02% |
05:50pm | Leerink Partners Cuts Price Target on Bristol-Myers Squibb to $47 From $51 | MT |
05:45pm | UBS Cuts Bristol-Myers Squibb Price Target to $47 From $52, Maintains Neutral Rating | MT |
Filters
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company